Jones Day advised Sanofi on the deal. Sanofi announced the sale of 2 portfolios of products for central nervous systems disorders and pain and vascular diseases to...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi, healthcare company that provides treatments and the protection of life-saving vaccines, announced the sale of a portfolio of 12 customer healthcare...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi, a healthcare company that provides treatments and the protection of life-saving vaccines, announced the sale of a portfolio of 5...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. SUBSTIPHARM, a privately held pharmaceutical group, announced the acquisition of the Japanese Encephalitis vaccine IMOJEV from Sanofi. Sanofi operates as...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi announced the sale of a portfolio of pharmaceutical products to Cheplapharm Arzneimittel GmbH, a German privately-owned company headquartered in...
You must be a Standard 1 Year member to access this content.
Jones Day advised Sanofi on the deal. Sanofi announced the sale to Hypera Pharma of 12 over-the-counter and prescription brands in Brazil, Colombia and Mexico, including mouthwash...
You must be a Standard 1 Year member to access this content.
Arnold & Porter advised Sanofi on the deal while Goodwin Procter represented Seagen. Sanofi announced its exclusive collaboration with Nasdaq-listed biotech Seagen Inc. to design, develop and...
You must be a Standard 1 Year member to access this content.
